Hip Tendinitis Market
Hip Tendinitis Market Analysis by Internal Snapping Hip, External Snapping Hip, and Intra-articular Snapping Hip Injury from 2023 to 2033
Analysis of Hip Tendinitis Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Hip Tendinitis Market Growth Outlook (2023 to 2033)
Expanding at a CAGR of 5%, the global hip tendinitis market is predicted to increase from a value of US$ 268.7 million in 2023 to US$ 437.8 million by the end of 2033.
Hip tendinitis is an uncomfortable inflammatory condition when a tendon in the hip becomes irritated or inflamed. Other names for it include hip tendonitis and hip flexor tendonitis. The rapidly increasing rate of the senior population worldwide and growing sports activities are primarily increasing the demand for hip tendonitis treatment.
A tendon, which joins muscles to the bones, is a thick cord comprised of microscopic fibers. People who have irritated or inflamed tendons may feel pain, soreness, and little swelling close to the affected joint. The hip is flexed by a muscle called the iliopsoas muscle, which is connected to the upper thigh via a tendon. Hip tendonitis can develop when this tendon becomes inflamed due to the muscle being overworked from too much exercise.
Athletes who engage in high-intensity sports or exercise programs, such as running, biking, or swimming, are more likely to experience hip tendinitis. Hip discomfort that comes on gradually is the main sign of hip tendonitis. Furthermore, it may result in soreness at the hip's tendon attachment point.
Iliopsoas tendinitis often leads to discomfort in the front of the hip. Hip tendinitis can worsen over time if left untreated. Hip tendinitis can decrease hip mobility by making hip movement difficult.
Internal snapping hip, external snapping hip, and intra-articular snapping hip are some of the types of hip tendinitis. Coxa Saltans, sometimes referred to as a dancer's hip or snapping hip syndrome, is a clinical ailment that is characterized by an audible or tactile snapping sensation that is experienced during the motion of the hip joint.
The iliopsoas tendon commonly causes an internal snapping hip when it ruptures over underlying bony prominences such as the anterior portion of the femoral head or the iliopectinal eminence. The snapping experience and intra-articular disease both start in the front hip region, therefore they can be very similar.
The cartilage of the hip joint thins and the surfaces of the joint grow rougher resulting in hip osteoarthritis pain. The prevalence of hip tendinitis is increasing due to rising cases of rheumatoid arthritis and diabetes, as well as the shift toward a sedentary lifestyle, which significantly contributes to the growth of the market for hip tendonitis treatment.
| Report Details | Report Attributes |
|---|---|
| Hip Tendinitis Market Size (2023E) | US$ 268.7 Million |
| Forecasted Market Value (2033F) | US$ 437.8 Million |
| Global Market Growth Rate (2023 to 2033) | 5% CAGR |
| Leading Regional Market | North America |
| Key Companies Profiled | Almatica Pharma, Inc; AstraZeneca; Bayer AG; Boehringer Ingelheim Pharmaceuticals, Inc; Merck & Co., Inc; Pfizer; Abbott; GlaxoSmithKline plc; Teva Pharmaceuticals; Lupin Pharmaceuticals, Inc.; Geri-Care Pharmaceuticals.; Perrigo Company |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Why are Sales of Hip Tendinitis Products Increasing Steadily?
“Rising Prevalence of Rheumatoid Arthritis”
- Global prevalence of rheumatoid arthritis (RA) was calculated to be 0.46% according to a study that was published in Rheumatology International in November 2020 with the title ‘The global prevalence of rheumatoid arthritis (RA): a meta-analysis based on a systematic review’.
Rheumatoid arthritis affects the connective tissues, muscles, joints, hip bone, fibrous tissue, and tendons around the hip in addition to being related to an inflammatory illness that produces hip inflammation and pain in the body's joints. The capacity to carry out health-related everyday activities, such as employment and domestic tasks, is significantly hampered by rheumatoid arthritis.
- According to the national center of biotechnology information, rheumatoid arthritis affects between 0.3% and 1% more people worldwide than in developing nations, especially women.
In both underdeveloped and developed countries, rheumatoid arthritis impairs the quality of life and causes early death. Rheumatoid arthritis is a severe, immobilizing condition that commonly results in deformity and pain. It typically develops between the ages of twenty and forty, the most active years of life.
An all-encompassing inflammatory condition known as rheumatoid arthritis manifests itself in many joints throughout the body. Although this inflammation usually affects the body's organs, it can also impact the lining of the joints. This inflammatory joint lining commonly occurs in cartilage damage, bone disintegration, and joint deformity. Thus the rising prevalence of rheumatoid arthritis is increasing the risk of hip tendonitis.
“Poor Diabetes Care Leading to Increased Cases of Chronic Hip Tendonitis”
Diabetes patients are significantly more likely to experience difficulties with their tendons than people without the disease, most likely as a result of the tendons' abnormally poor blood flow. This indicates that the tendons may have extremely early diabetic blood vessel alterations. High blood sugar levels could result in aberrant thickening of the tendons, which is another potential result of tendinitis in the hip.
Advanced glycation end-products (AGEs), which are present in both type 1 and type 2 diabetes, induce tendon injury. They develop as a result of blood sugar and protein or fat combining. The body typically produces AGEs slowly and steadily. But, having diabetes causes the excess sugar in the blood to speed up, which impacts tendons and results in hip pain tendonitis.
Collagen is a protein that is used to make tendons. It forms a connection with AGEs that may alter the structure of the tendons and impact their functionality. For example, they might become thicker than usual and lose some of their previous capacity to support the weight. As a result, the chances of developing a tendon tear increase. In comparison to non-diabetics, people with type II diabetes mellitus (T2DM) have a fourfold increased risk of tendinopathy and a fivefold increased risk of tendon rupture or tear.
What is Lowering Demand for Hip Tendinitis Products to Some Extent?
“High Treatment Costs Involved”
Various hip tendonitis therapies can be used to treat inflamed hip pain. Physical therapy such as hip tendinitis stretching is one of the most commonly used treatment procedures.
Continuous advancements have introduced effective hip tendonitis therapies such as stem cell therapy, hip replacement tendonitis, extracorporeal shock wave therapy, sclerotherapy, and more. Thus, the introduction of advanced treatment procedures increases the treatment cost. Patients with chronic hip tendonitis in developing countries may avoid the latest treatment procedures due to high cost and lack of spending power, this may further hamper sales of hip tendinitis solutions.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Analysis
Why is the United States a Profitable Market for Hip Tendinitis Solution Suppliers?
“Increasing Rate of Sport-related Injuries”
- According to the national center of biotechnology information, in the United States, about 300,000 tendon repairs are carried out each year to fix damage to tendons brought on by either acute trauma or long-term tendinopathy.
The presence of advanced healthcare facilities, the existence of major hip tendinitis companies, and rising cases of orthopedic conditions are all boosting the United States market for hip tendonitis.
- Over 115,790 swimming-related injuries were treated in emergency departments in 2021, according to statistics from the National Safety Council (NSC) that were updated in 2022, with children under the age of 14 accounting for half of all injuries.
- Also, 3.2 million people needed emergency room treatment in 2021 for accidents involving sporting goods and recreational equipment. Basketball, cycling, and exercising are the most common activities linked to accidents.
Why are Cases of Hip Tendonitis Increasing Rapidly in Japan?
“Rising Cases of Hip Tendinitis As Country Continues to Grey”
Rapidly developing healthcare systems and the introduction of advanced medical technologies are expected to boost the demand for hip tendinitis technologies in Japan. The swiftly increasing rate of the older population (who are more prone to orthopedic problems) is also aiding sales growth.
- Statista estimates that in 2021, the proportion of Japanese citizens aged 65 and over to the entire population was around 29.8%. People 65 years of age and older are predicted to make up nearly 38% of the population in Japan by 2060 as a result of a low birth rate and high life expectancy.
Thus, increasing risk of hip tendonitis in older people and advancements in the medical field are driving the hip tendinitis industry growth in Japan.
How is the Market for Hip Tendinitis Progressing in Germany?
“High Rate of Diabetes Increasing Risk of Improper Blood Flow to Tendons”
In recent years, cases of diabetes are increasing alarmingly in Germany. Diabetes patients need to make numerous adjustments throughout the day to keep their blood sugar levels within normal ranges, avoid injuries, maintain their diets, and more. Obesity, an unhealthy diet, and lack of exercise are the main causes of the rise in newly diagnosed Type 1 and Type 2 diabetes cases.
Tendonitis cases are on the upsurge, as evidenced by the rapidly rising incidence and prevalence of diabetic patients. Tendon rupture and tendinopathy are two musculoskeletal conditions that are commonly seen by patients with diabetes mellitus (DM).
- According to DZD - German Center for Diabetes Research, around 7.2 percent of the population in Germany currently has diabetes, the majority of which is type 2 diabetes. The same source estimates that, over the next 20 years, there will be a huge rise in the population of diabetic patients.
Category-wise Analysis
Which Kind of Treatment Method is Widely Popular?
“Physical Therapy Mostly Preferred by Patients”
Diagnosis and therapy are two types of hip tendinitis treatment procedures. The diagnosis treatment includes a physical examination, imaging studies, and others. Physical therapy's efficiency and results, such as providing patients with quicker alleviation, are currently boosting demand.
The therapy is further segmented into pharmacological, non-pharmacological, shock wave or surgery, and medical equipment. The increasing preference of hip tendinitis patients towards non-invasive treatment methods is expected to boost hip tendinitis therapy demand during the forecast period.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Competitive Landscape
Athletes and sports players commonly experience tendon-related injuries; the rising prevalence of these ailments in the general population is attributable to an increase in the need for tendonitis treatment options throughout the projected period.
According to Fact.MR, a market research and competitive intelligence provider, key players in the hip tendinitis market are developing effective product development plans and launching numerous initiatives to increase their company footprint in response to the rising demand. One of the main reasons behind the industry's growth is the well-balanced presence of regional producers with well-known companies working in international markets.
- In November 2022, Camber Pharmaceuticals added Naproxen Oral Suspension to its line of products since it is used to treat the symptoms and signs of tendinitis.
Key Segments of Hip Tendinitis Industry Research
-
By Injury Type :
- Internal Snapping Hip
- External Snapping Hip
- Intra-articular Snapping Hip
-
By Treatment :
- Diagnosis
- Physical Examination
- Imaging Studies
- Therapy
- Pharmacological
- Non-pharmacological
- Shock Wave or Surgery
- Medical Equipment
- Diagnosis
-
By End User :
- Hospitals & Clinics
- Medical Research Centers
- Academic Institutes
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
Table of Content
- 1. Global Market - Executive Summary
- 2. Global Market Overview
- 3. Market Risks and Trends Assessment
- 4. Market Background and Foundation Data Points
- 5. Global Market Demand (US$ Mn) Analysis 2018 to 2022 and Forecast, 2023 to 2033
- 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Injury Type
- 6.1. Internal Snapping Hip
- 6.2. External Snapping Hip
- 6.3. Intra-articular Snapping Hip
- 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Treatment
- 7.1. Diagnosis
- 7.2. Therapy
- 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by End User
- 8.1. Hospitals & Clinics
- 8.2. Medical Research Centers
- 8.3. Academic Institutes
- 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Region
- 9.1. North America
- 9.2. Latin America
- 9.3. Europe
- 9.4. East Asia
- 9.5. South Asia & Oceania
- 9.6. Middle East and Africa (MEA)
- 10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
- 11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
- 12. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033
- 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033
- 14. South Asia & Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033
- 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033
- 16. Market Structure Analysis
- 17. Competition Analysis
- 17.1. Almatica Pharma, Inc
- 17.2. AstraZeneca
- 17.3. Bayer AG
- 17.4. Boehringer Ingelheim Pharmaceuticals, Inc
- 17.5. Merck & Co., Inc
- 17.6. Pfizer
- 17.7. Abbott
- 17.8. GlaxoSmithKline plc
- 17.9. Teva Pharmaceuticals
- 17.10. Lupin Pharmaceuticals, Inc.
- 17.11. Geri-Care Pharmaceuticals
- 17.12. Perrigo Company
- 18. Assumptions And Acronyms Used
- 19. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market Value (US$ Mn) Analysis, by Injury Type, 2018 to 2022
Table 2: Global Market Value (US$ Mn) Analysis, by Injury Type, 2023 to 2033
Table 3: Global Market Value (US$ Mn) Opportunity Analysis, by Injury Type, 2023 to 2033
Table 4: Global Market Value (US$ Mn) Analysis, by Treatment, 2018 to 2022
Table 5: Global Market Value (US$ Mn) Analysis, by Treatment, 2023 to 2033
Table 6: Global Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2023 to 2033
Table 7: Global Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 8: Global Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 9: Global Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
Table 10: Global Market Value (US$ Mn) Analysis, by Region, 2018 to 2022
Table 11: Global Market Value (US$ Mn) Analysis, by Region, 2023 to 2033
Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2023 to 2033
Table 13: North America Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 14: North America Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 16: North America Market Value (US$ Mn) Analysis, by Injury Type, 2018 to 2022
Table 17: North America Market Value (US$ Mn) Analysis, by Injury Type, 2023 to 2033
Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Injury Type, 2023 to 2033
Table 19: North America Market Value (US$ Mn) Analysis, by Treatment, 2018 to 2022
Table 20: North America Market Value (US$ Mn) Analysis, by Treatment, 2023 to 2033
Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2023 to 2033
Table 22: North America Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 23: North America Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
Table 25: Latin America Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 26: Latin America Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 28: Latin America Market Value (US$ Mn) Analysis, by Injury Type, 2018 to 2022
Table 29: Latin America Market Value (US$ Mn) Analysis, by Injury Type, 2023 to 2033
Table 30: Latin America Market Value (US$ Mn) Opportunity Analysis, by Injury Type, 2023 to 2033
Table 31: Latin America Market Value (US$ Mn) Analysis, by Treatment, 2018 to 2022
Table 32: Latin America Market Value (US$ Mn) Analysis, by Treatment, 2023 to 2033
Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2023 to 2033
Table 34: Latin America Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 35: Latin America Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
Table 37: Europe Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 38: Europe Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 39: Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 40: Europe Market Value (US$ Mn) Analysis, by Injury Type, 2018 to 2022
Table 41: Europe Market Value (US$ Mn) Analysis, by Injury Type, 2023 to 2033
Table 42: Europe Market Value (US$ Mn) Opportunity Analysis, by Injury Type, 2023 to 2033
Table 43: Europe Market Value (US$ Mn) Analysis, by Treatment, 2018 to 2022
Table 44: Europe Market Value (US$ Mn) Analysis, by Treatment, 2023 to 2033
Table 45: Europe Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2023 to 2033
Table 46: Europe Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 47: Europe Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 48: Europe Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
Table 49: East Asia Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 50: East Asia Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 51: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 52: East Asia Market Value (US$ Mn) Analysis, by Injury Type, 2018 to 2022
Table 53: East Asia Market Value (US$ Mn) Analysis, by Injury Type, 2023 to 2033
Table 54: East Asia Market Value (US$ Mn) Opportunity Analysis, by Injury Type, 2023 to 2033
Table 55: East Asia Market Value (US$ Mn) Analysis, by Treatment, 2018 to 2022
Table 56: East Asia Market Value (US$ Mn) Analysis, by Treatment, 2023 to 2033
Table 57: East Asia Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2023 to 2033
Table 58: East Asia Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 59: East Asia Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 60: East Asia Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
Table 61: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 62: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 63: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 64: South Asia & Oceania Market Value (US$ Mn) Analysis, by Injury Type, 2018 to 2022
Table 65: South Asia & Oceania Market Value (US$ Mn) Analysis, by Injury Type, 2023 to 2033
Table 66: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Injury Type, 2023 to 2033
Table 67: South Asia & Oceania Market Value (US$ Mn) Analysis, by Treatment, 2018 to 2022
Table 68: South Asia & Oceania Market Value (US$ Mn) Analysis, by Treatment, 2023 to 2033
Table 69: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2023 to 2033
Table 70: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 71: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 72: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
Table 73: MEA Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 74: MEA Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 75: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 76: MEA Market Value (US$ Mn) Analysis, by Injury Type, 2018 to 2022
Table 77: MEA Market Value (US$ Mn) Analysis, by Injury Type, 2023 to 2033
Table 78: MEA Market Value (US$ Mn) Opportunity Analysis, by Injury Type, 2023 to 2033
Table 79: MEA Market Value (US$ Mn) Analysis, by Treatment, 2018 to 2022
Table 80: MEA Market Value (US$ Mn) Analysis, by Treatment, 2023 to 2033
Table 81: MEA Market Value (US$ Mn) Opportunity Analysis, by Treatment, 2023 to 2033
Table 82: MEA Market Value (US$ Mn) Analysis, by End User, 2018 to 2022
Table 83: MEA Market Value (US$ Mn) Analysis, by End User, 2023 to 2033
Table 84: MEA Market Value (US$ Mn) Opportunity Analysis, by End User, 2023 to 2033
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 2: Global Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 3: Global Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 4: Global Market Incremental $ Opportunity, 2023 to 2033
Figure 5: Global Market Share and BPS Analysis by Injury Type, 2023 & 2033
Figure 6: Global Market Y-o-Y Growth Projections by Injury Type, 2023 to 2033
Figure 7: Global Market Attractiveness Analysis by Injury Type, 2023 to 2033
Figure 8: Global Market Share and BPS Analysis by Treatment, 2023 & 2033
Figure 9: Global Market Y-o-Y Growth Projections by Treatment, 2023 to 2033
Figure 10: Global Market Attractiveness Analysis by Treatment, 2023 to 2033
Figure 11: Global Market Share and BPS Analysis by End User, 2023 & 2033
Figure 12: Global Market Y-o-Y Growth Projections by End User, 2023 to 2033
Figure 13: Global Market Attractiveness Analysis by End User, 2023 to 2033
Figure 14: Global Market Share and BPS Analysis by Region, 2023 & 2033
Figure 15: Global Market Y-o-Y Growth Projections by Region, 2023 to 2033
Figure 16: Global Market Attractiveness Analysis by Region, 2023 to 2033
Figure 17: North America Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 18: North America Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 19: North America Market Value Y-o-Y Growth and Forecast, 2033
Figure 20: North America Market Incremental $ Opportunity, 2023 to 2033
Figure 21: North America Market Share Analysis by Country, 2023 & 2033
Figure 22: North America Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 23: North America Market Attractiveness Analysis by Country, 2023 to 2033
Figure 24: North America Market Share and BPS Analysis by Injury Type, 2023 & 2033
Figure 25: North America Market Y-o-Y Growth Projections by Injury Type, 2023 to 2033
Figure 26: North America Market Attractiveness Analysis by Injury Type, 2023 to 2033
Figure 27: North America Market Share and BPS Analysis by Treatment, 2023 & 2033
Figure 28: North America Market Y-o-Y Growth Projections by Treatment, 2023 to 2033
Figure 29: North America Market Attractiveness Analysis by Treatment, 2023 to 2033
Figure 30: North America Market Share and BPS Analysis by End User, 2023 & 2033
Figure 31: North America Market Y-o-Y Growth Projections by End User, 2023 to 2033
Figure 32: North America Market Attractiveness Analysis by End User, 2023 to 2033
Figure 33: Latin America Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 34: Latin America Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 35: Latin America Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 36: Latin America Market Incremental $ Opportunity, 2023 to 2033
Figure 37: Latin America Market Share Analysis by Country, 2023 & 2033
Figure 38: Latin America Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 39: Latin America Market Attractiveness Analysis by Country, 2023 to 2033
Figure 40: Latin America Market Share and BPS Analysis by Injury Type, 2023 & 2033
Figure 41: Latin America Market Y-o-Y Growth Projections by Injury Type, 2023 to 2033
Figure 42: Latin America Market Attractiveness Analysis by Injury Type, 2023 to 2033
Figure 43: Latin America Market Share and BPS Analysis by Treatment, 2023 & 2033
Figure 44: Latin America Market Y-o-Y Growth Projections by Treatment, 2023 to 2033
Figure 45: Latin America Market Attractiveness Analysis by Treatment, 2023 to 2033
Figure 46: Latin America Market Share and BPS Analysis by End User, 2023 & 2033
Figure 47: Latin America Market Y-o-Y Growth Projections by End User, 2023 to 2033
Figure 48: Latin America Market Attractiveness Analysis by End User, 2023 to 2033
Figure 49: Europe Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 50: Europe Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 51: Europe Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 52: Europe Market Incremental $ Opportunity, 2023 to 2033
Figure 53: Europe Market Share Analysis by Country, 2023 & 2033
Figure 54: Europe Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 55: Europe Market Attractiveness Analysis by Country, 2023 to 2033
Figure 56: Europe Market Share and BPS Analysis by Injury Type, 2023 & 2033
Figure 57: Europe Market Y-o-Y Growth Projections by Injury Type, 2023 to 2033
Figure 58: Europe Market Attractiveness Analysis by Injury Type, 2023 to 2033
Figure 59: Europe Market Share and BPS Analysis by Treatment, 2023 & 2033
Figure 60: Europe Market Y-o-Y Growth Projections by Treatment, 2023 to 2033
Figure 61: Europe Market Attractiveness Analysis by Treatment, 2023 to 2033
Figure 62: Europe Market Share and BPS Analysis by End User, 2023 & 2033
Figure 63: Europe Market Y-o-Y Growth Projections by End User, 2023 to 2033
Figure 64: Europe Market Attractiveness Analysis by End User, 2023 to 2033
Figure 65: East Asia Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 66: East Asia Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 67: East Asia Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 68: East Asia Market Incremental $ Opportunity, 2023 to 2033
Figure 69: East Asia Market Share Analysis by Country, 2023 & 2033
Figure 70: East Asia Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 71: East Asia Market Attractiveness Analysis by Country, 2023 to 2033
Figure 72: East Asia Market Share and BPS Analysis by Injury Type, 2023 & 2033
Figure 73: East Asia Market Y-o-Y Growth Projections by Injury Type, 2023 to 2033
Figure 74: East Asia Market Attractiveness Analysis by Injury Type, 2023 to 2033
Figure 75: East Asia Market Share and BPS Analysis by Treatment, 2023 & 2033
Figure 76: East Asia Market Y-o-Y Growth Projections by Treatment, 2023 to 2033
Figure 77: East Asia Market Attractiveness Analysis by Treatment, 2023 to 2033
Figure 78: East Asia Market Share and BPS Analysis by End User, 2023 & 2033
Figure 79: East Asia Market Y-o-Y Growth Projections by End User, 2023 to 2033
Figure 80: East Asia Market Attractiveness Analysis by End User, 2023 to 2033
Figure 81: South Asia & Oceania Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 82: South Asia & Oceania Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 83: South Asia & Oceania Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 84: South Asia & Oceania Market Incremental $ Opportunity, 2023 to 2033
Figure 85: South Asia & Oceania Market Share Analysis by Country, 2023 & 2033
Figure 86: South Asia & Oceania Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 87: South Asia & Oceania Market Attractiveness Analysis by Country, 2023 to 2033
Figure 88: South Asia & Oceania Market Share and BPS Analysis by Injury Type, 2023 & 2033
Figure 89: South Asia & Oceania Market Y-o-Y Growth Projections by Injury Type, 2023 to 2033
Figure 90: South Asia & Oceania Market Attractiveness Analysis by Injury Type, 2023 to 2033
Figure 91: South Asia & Oceania Market Share and BPS Analysis by Treatment, 2023 & 2033
Figure 92: South Asia & Oceania Market Y-o-Y Growth Projections by Treatment, 2023 to 2033
Figure 93: South Asia & Oceania Market Attractiveness Analysis by Treatment, 2023 to 2033
Figure 94: South Asia & Oceania Market Share and BPS Analysis by End User, 2023 & 2033
Figure 95: South Asia & Oceania Market Y-o-Y Growth Projections by End User, 2023 to 2033
Figure 96: South Asia & Oceania Market Attractiveness Analysis by End User, 2023 to 2033
Figure 97: MEA Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 98: MEA Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 99: MEA Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 100: MEA Market Incremental $ Opportunity, 2023 to 2033
Figure 101: MEA Market Share Analysis by Country, 2023 & 2033
Figure 102: MEA Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 103: MEA Market Attractiveness Analysis by Country, 2023 to 2033
Figure 104: MEA Market Share and BPS Analysis by Injury Type, 2023 & 2033
Figure 105: MEA Market Y-o-Y Growth Projections by Injury Type, 2023 to 2033
Figure 106: MEA Market Attractiveness Analysis by Injury Type, 2023 to 2033
Figure 107: MEA Market Share and BPS Analysis by Treatment, 2023 & 2033
Figure 108: MEA Market Y-o-Y Growth Projections by Treatment, 2023 to 2033
Figure 109: MEA Market Attractiveness Analysis by Treatment, 2023 to 2033
Figure 110: MEA Market Share and BPS Analysis by End User, 2023 & 2033
Figure 111: MEA Market Y-o-Y Growth Projections by End User, 2023 to 2033
Figure 112: MEA Market Attractiveness Analysis by End User, 2023 to 2033
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the value of the hip tendinitis market in 2023?
The global hip tendinitis market is currently valued at US$ 268.7 million.
What will be the market size for hip tendinitis by 2033?
The market for hip tendinitis is projected to reach US$ 437.8 million by 2033.
What is the predicted growth rate for the hip tendinitis market?
Global demand for hip tendinitis solutions is expected to rise at a CAGR of 5% from 2023 to 2033.
Which factor is driving the sales of hip tendinitis products?
Rising prevalence of diabetes and rheumatoid arthritis is driving market growth.
Who are the leading producers of hip tendinitis products?
Almatica Pharma, Inc, AstraZeneca, and Bayer AG are some of the leading hip tendinitis product companies.
Hip Tendinitis Market